Interpace Diagnostics Group Stock Price and Value Analysis

Should you buy Interpace Diagnostics Group stock? (NasdaqCM:IDXG). Let's see how it does in our automated value investing analysis system.

IDXG Free Cash Flow Trend

Free Cash Flow trendline for IDXG
Free Cash Flow trendline for Interpace Diagnostics Group

Hmm, we can't give any reliable projection for Interpace Diagnostics Group's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company is not making money.
  • This company pays no dividend.

Inside the IDXG Numbers

IDXG Price
(Interpace Diagnostics Group stock price per share)
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Diagnostics & Research stocks
[?] Free Cash Flow Jitter 48%

Is Interpace Diagnostics Group Stock on Sale?

Based on our analysis, we believe that you should not buy Interpace Diagnostics Group right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy IDXG Stock?

Does Interpace Diagnostics Group have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.